Osteopontin expression in the liver with severe perisinusoidal fibrosis: Autopsy case of Down syndrome with transient myeloproliferative disorder

Pathology International

Volumn 58, Issue 1, 2008, Pages 64-68

  Tokairin, Takuo ^a   Nishikawa, Yuji ^a   Watanabe, Hitoshi ^a   Doi, Yuko ^a   Omori, Yasufumi ^a   Yoshioka, Toshiaki ^a   Yamamoto, Youhei ^a   Yoshida, Masayuki ^a   Nishimura, Takuya ^a   Li, Qinchang ^a   Arai, Hirokazu ^a   Ishida, Akira ^a   Takada, Goro ^a   Enomoto, Katsuhiko ^a  

^a AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Down syndrome; Hepatic stellate cell; Osteopontin; Perisinusoidal liver fibrosis; Transient myeloproliferative disorder

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; OSTEOPONTIN; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CASE REPORT; CELL INFILTRATION; DOWN SYNDROME; HUMAN; IMMUNOHISTOCHEMISTRY; INFANT; LIVER CELL; LIVER FIBROSIS; LIVER SINUSOID; MACROPHAGE; MALE; MEGAKARYOCYTE; MYELOPROLIFERATIVE DISORDER; PRIORITY JOURNAL; PROTEIN EXPRESSION; STELLATE CELL;

AUTOPSY; DOWN SYNDROME; HEPATOCYTES; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT, NEWBORN; LIVER CIRRHOSIS; MALE; MYELOPROLIFERATIVE DISORDERS; OSTEOPONTIN; TRANSFORMING GROWTH FACTOR BETA1;

EID: 36649038972     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2007.02191.x     Document Type: Article

References (32)

1. Ruchelli ED, Uri A, Dimmick JE et al. Severe perinatal liver disease and Down syndrome: An apparent relationship. Hum Pathol 1991 22 : 1274 80.
2. Miyauchi J, Ito Y, Kawano T, Tsunematu Y, Shimizu K. Unusual diffuse liver fibrosis accompanying transient myeloproliferative disorder in Down's syndrome: A report of four autopsy cases and proposal of a hypothesis. Blood 1992 80 : 1521 7.
3. Becroft DMO. Fetal megakaryocytic dyshemopoiesis in Down syndrome: Association with hepatic and pancreatic fibrosis. Pediatr Pathol 1993 13 : 811 20.
4. Yagihashi N, Watanabe K, Yagihashi S. Transient abnormal myelopoiesis accompanied by hepatic fibrosis in two infants with Down syndrome. J Clin Pathol 1995 48 : 973 5.
5. Schwab M, Niemeyer C, Schwarzer U. Down syndrome, transient myeloproliferative disorder, and infantile liver fibrosis. Med Pediatr Oncol 1998 31 : 159 65.
6. Arai H, Ishida A, Nakajima W, Nishinomiya F, Yamazoe A, Takada G. Immunohistochemical study on transforming growth factor-beta1 expression in liver fibrosis of Down's syndrome with transient abnormal myelopoiesis. Hum Pathol 1999 30 : 474 6.
7. Hattori H, Matsuzaki A, Suminoe A, Ihara K, Nakayama H, Hara T. High expression of platelet-derived growth factor and transforming growth factor-β1 in blast cells from patients with Down Syndrome suffering from transient myeloproliferative disorder and organ fibrosis. Br J Haematol 2001 115 : 472 5.
8. Friedman SL. Liver fibrosis-From bench to bedside. J Hepatol 2003 38 : s38 53.
9. Yang C, Zeisberg M, Mosterman B et al. Liver fibrosis: Insights into migration of hepatic stellate cells in response to extracellular matrix and growth factors. Gastroenterology 2003 124 : 147 59.
10. Bataller R, Brenner DA. Liver fibrosis. J Clin Invest 2005 115 : 209 18.
11. Denhardt DT, Noda M, O'Regan AW, Pavlin D, Berman JS. Osteopontin as a means to cope with environmental insults: Regulation of inflammation, tissue remodeling, and cell survival. J Clin Invest 2001 107 : 1055 61.
12. Kawashima R, Mochida S, Matsui A et al. Expression of osteopontin in Kupffer cells and hepatic macrophages and stellate cells in rat liver after carbon tetrachloride intoxication: A possible factor for macrophage migration into hepatic necrotic areas. Biochem Biophys Res Commun 1999 256 : 527 31.
13. Sahai A, Malladi P, Melin-Aldana H, Green RM, Whitington PF. Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a dietary murine model. Am J Physiol Gastrointest Liver Physiol 2004 287 : G264 73.
14. Sahai A, Malladi P, Pan X et al. Obese and diabetic db/db mice develop marked liver fibrosis in a model of nonalcoholic steatohepatitis: Role of short-form leptin receptors and osteopontin. Am J Physiol Gastrointest Liver Physiol 2004 287 : G1035 43.
15. Lorena D, Darby IA, Gadeau A-P et al. Osteopontin expression in normal and fibrotic liver. Altered liver healing in osteopontin-deficient mice. J Hepatol 2006 44 : 383 90.
16. Lefkowitch JH. Morphology of alcoholic liver disease. Clin Liver Dis 2005 9 : 37 53.
17. Hübscher SG. Histological assessment of non-alcoholic fatty liver disease. Histopathology 2006 49 : 450 65.
18. Brown LF, Berse B, Van de Water L et al. Expression and distribution of osteopontin in human tissues: Widespread association with luminal epithelial surfaces. Mol Biol Cell 1992 3 : 1169 80.
19. Whitington PF, Malladi P, Melin-Aldana H, Azzam R, Mack CL, Sahai A. Expression of osteopontin correlates with portal biliary proliferation and fibrosis in biliary atresia. Pediatr Res 2005 57 : 837 44.
20. Tajiri T, Tate G, Kunimura T et al. Osteopontin expression in proliferated bile ductules: The correlation with liver damage in fulminant hepatitis. Dig Dis Sci 2005 50 : 188 95.
21. Arai M, Yokosuka O, Kanda T et al. Serum osteopontin levels in patients with acute liver dysfunction. Scand J Gastroenterol 2006 41 : 102 10.
22. Harada K, Ozaki S, Sudo Y, Tsuneyama K, Ohta H, Nakanuma Y. Osteopontin is involved in the formation of epithelioid granuloma and bile duct injury in primary biliary cirrhosis. Pathol Int 2003 53 : 8 17.
23. Gotoh M, Sakamoto M, Kanetaka K, Chuuma M, Hirohashi S. Overexpression of osteopontin in hepatocellular carcinoma. Pathol Int 2002 52 : 19 24.
24. Terashi T, Aishima S, Taguchi K et al. Decreased expression of osteopontin is related to tumor aggressiveness and clinical outcome of intrahepatic cholangiocarcinoma. Liver Int 2004 24 : 38 45.
25. Nishikawa Y, Doi Y, Watanabe H et al. Transdifferentiation of mature rat hepatocytes into bile duct-like cells in vitro. Am J Pathol 2005 166 : 1077 88.
26. Lee SH, Seo GS, Park YN, Yoo TM, Sohn DH. Effects and regulation of osteopontin in rat hepatic stellate cells. Biochem Pharmacol 2004 68 : 2367 78.
27. 3 integrin stimulates immediate cell signals in osteoclasts. J Biol Chem 1991 266 : 20 69 74.
28. 5. J Biol Chem 1995 270 : 26 32 8.
29. Carloni V, Romanelli RG, Pinzani M, Laffi G, Gentilini P. Expression and function of integrin receptors for collagen and laminin in cultured human hepatic stellate cells. Gastroenterology 1996 110 : 1127 36.
30. 3 integrin regulates proliferation and apoptosis of hepatic stellate cells. J Biol Chem 2004 279 : 23 96 4006.
31. Bissell DM, Roulot D, George J. Transforming growth factor β and liver. Hepatology 2001 34 : 857 67.
32. Gressner AM, Weiskirchen R. Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-β as major players and therapeutic targets. J Cell Mol Med 2006 10 : 76 99.